Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Knowledge insufficient: the management of haemoglobin SC disease.

British journal of haematology - 1 Feb 2017

Pecker Lydia H, Schaefer Beverly A, Luchtman-Jones Lori

Abstract excerpt

Although haemoglobin SC (HbSC) accounts for 30% of sickle cell disease (SCD) in the United States and United Kingdom, evidence-based guidelines for genotype specific management are lacking. The unique pathology of HbSC disease is complex, characterized by erythrocyte dehydration, intracellular sickling and increased blood viscosity. The evaluation and treatment of patients with HbSC is largely inferred from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Management
Share to Erythrocytes, Abnormal
Share to SCD gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Quality of Life

Source

Open in PubMed Open full text

Identifiers

PMID: 27982424
DOI: 10.1111/bjh.14444
PMCID: PMC5303157

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Knowledge insufficient: the management of haemoglobin SC disease.PMID 27982424Read ↗

The paradox of HbSC disease-Not so benign after all.Semantic proximity Read ↗

Current and emerging treatments for sickle cell diseaseSemantic proximity Read ↗

Sickle Cell Disease.Semantic proximity Read ↗

Sickle Cell DiseaseSemantic proximity Read ↗

Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular levelSemantic proximity Read ↗

Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approachesSemantic proximity Read ↗

Is There a Difference in Occurrence of Complications Between Adults With Hemoglobin SS and Hemoglobin SC Disease: An Extended Systematic Review.Semantic proximity Read ↗

HAEMOGLOBINOPATHIESSemantic proximity Read ↗

HAEMOGLOBINOPATHIESSemantic proximity Read ↗

Definitions of the phenotypic manifestations of sickle cell disease.Semantic proximity Read ↗

Disease burden, management strategies, and unmet needs in α-thalassemia due to hemoglobin H disease.Semantic proximity Read ↗

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical ManagementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.